Cobalt(II) complexes with the non-steroidal anti-inflammatory drug mefenamic acid in the presence or absence of nitrogen donor heterocyclic ligands (2,2'-bipyridine, 1,10-phenanthroline or pyridine) have been synthesized and characterized with physicochemical and spectroscopic techniques. The experimental data suggest that mefenamic acid acts as deprotonated monodentate ligand coordinated to Co(II) ion through a carboxylato oxygen. The crystal structures of tetrakis(methanol)bis-(mefenamato)cobalt(II), 1 and (2,2'-bipyridine)bis(methanol)bis(mefenamato)cobalt(II), 2 have been determined by X-ray crystallography. The EPR spectra of complexes 1 and 2 in frozen solution reveal that they retain their structures. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and bis(methanol)bis(pyridine)bis-(mefenamato)cobalt(II) exhibits the highest binding constant. Competitive study with ethidium bromide (EB) has shown that the complexes can displace the DNA-bound EB indicating that they bind to DNA in strong competition with EB. The cyclic voltammograms of the complexes recorded in dmso solution and in the presence of CT DNA in 1 : 2 dmso : buffer (containing 150 mM NaCl and 15 mM trisodium citrate at pH 7.0) solution have shown that they can bind to CT DNA by the intercalative binding mode. Mefenamic acid and its cobalt(II) complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. The antioxidant activity of the compounds has been evaluated indicating their high scavenging activity against hydroxyl free radicals and superoxide radicals.

Copper(II) complexes with the non-steroidal antiinflammatory drug mefenamic acid in the presence of aqua or nitrogen donor heterocyclic ligands (2,2'-bipyridine, 1,10-phenanthroline, 2,2'-bipyridylamine or pyridine) have been synthesized and characterized. The crystal structures of [(2,2'-bipyridine)bis(mefenamato)copper(II)], 2, [(2,2'-bipyridylamine)bis(mefenamato)copper(II)], 4, and [bis(pyridine)bis(methanol)bis(mefenamato)copper(II)], 5, have been determined by X-ray crystallography. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and [bis(aqua)tetrakis(mefenamato)dicopper(II)] exhibits the highest binding constant to CT DNA. The cyclic voltammograms of the complexes in the presence of CT DNA solution have shown that the complexes can bind to CT DNA by the intercalative binding mode verified also by DNA solution viscosity measurements. Competitive studies with ethidium bromide (EB) indicate that the complexes can displace the DNA-bound EB suggesting strong competition with EB. Mefenamic acid and its complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. All the compounds have been tested for their antioxidant and free radical scavenging activity as well as for their in vitro inhibitory activity against soybean lipoxygenase showing significant activity.

The reaction between oxide-centered, triangular [MnIII3O(O2CR)6(py)3](ClO4) (R = Me (1), Et (2), Ph (3)) compounds and methyl 2-pyridyl ketone oxime (mpkoH) affords a new family of Mn/carboxylato/oximato complexes, [MnIII3O(O2CR)3(mpko)3](ClO4) [R = Me (4), Et (5), and Ph (6)]. As in 1-3, the cations of 4-6 contain an [MnIII3(mu3-O)]7+ triangular core, but with each Mn2 edge now bridged by an eta1:eta1:mu-RCO2- and an eta1:eta1:eta1:mu-mpko- group. The tridentate binding mode of the latter causes a buckling of the formerly planar [MnIII3(mu3-O)]7+ core, resulting in a relative twisting of the three MnIII octahedra and the central O2- ion now lying approximately 0.3 A above the Mn3 plane. This structural distortion leads to ferromagnetic exchange interactions within the molecule and a resulting S = 6 ground state. Fits of dc magnetization data for 4-6 collected in the 1.8-10.0 K and 10-70 kG ranges confirmed S = 6 ground states, and gave the following D and g values: -0.34 cm(-1) and 1.92 for 4, -0.34 cm(-1) and 1.93 for 5, and -0.35 cm(-1) and 1.99 for 6, where D is the axial zero-field splitting (anisotropy) parameter. Complexes 4-6 all exhibit frequency-dependent out-of-phase (chi" M) ac susceptibility signals suggesting them possibly to be single-molecule magnets (SMMs). Relaxation rate vs T data for complex 4 down to 1.8 K obtained from the chi" M vs T studies were supplemented with rate vs T data measured to 0.04 K via magnetization vs time decay studies, and these were used to construct Arrhenius plots from which was obtained the effective barrier to relaxation (Ueff) of 10.9 K. Magnetization vs dc field sweeps on single-crystals of 4.3CH2Cl2 displayed hysteresis loops exhibiting steps due to quantum tunneling of magnetization (QTM). The loops were essentially temperature-independent below approximately 0.3 K, indicating only ground-state QTM between the lowest-lying Ms = +/-6 levels. Complexes 4-6 are thus confirmed as the first triangular SMMs. High-frequency EPR spectra of single crystals of 4.3CH2Cl2 have provided precise spin Hamiltonian parameters, giving D = -0.3 cm(-1), B40 = -3 x 10(-5) cm(-1), and g = 2.00. The spectra also suggest a significant transverse anisotropy of E > or = 0.015 cm(-1). The combined work demonstrates the feasibility that structural distortions of a magnetic core imposed by peripheral ligands can "switch on" the properties of an SMM.

No abstract

Single-molecule magnets (SMMs) [1,2] are molecular species that can retain magnetization in the absence of a magnetic field below a blocking temperature. They represent the smallest possible magnetic storage device, which retains information in a single molecule rather than in a magnetic particle or array of particles. Furthermore, such molecules straddle the classical/quantum interface in also displaying quantum tunneling of magnetization and quantum phase interference. The SMM behavior derives from the intrinsic intramolecular properties of a high-spin ground state, and large and negative (easy axis type) magnetoanisotropy. [1,2] Experimentally, a SMM exhibits both a frequency-dependent out-of-phase alternating current (ac) magnetic susceptibility (c'') signal and hysteresis loops in magnetization versus direct current (dc) field studies.[ nÀ (n = 0, 1, 2; x = 3, 4; Mn III 8 Mn IV 4 for n = 0) and their derivatives, [1,2] but there are a number of other examples of SMMs containing manganese (at the oxidation states ii/iii, iii/iv or ii/iii/iv), iron, cobalt, nickel, and vanadium. [1][2][3] Important to the future of the field of SMMs is the development of new synthetic schemes that can yield molecules with a large spin and/or anisotropy. Herein we report access to the first members of a new class of manganese-based SMMs consisting exclusively of Mn III ions with T B (T B = blocking temperature) greater than 2 K.

Citrate is abundantly encountered in biological fluids as a natural metal ion chelator. Vanadium participates in biological processes as a catalyst in the active sites of metalloenzymes, as a metabolic regulator, as a mitogenic activator, and as an insulin-mimicking agent. Thus, vanadium chemistry with natural chelators, such as citrate, may have immediate implications on its role in a cellular milieu, and its action as a biological agent. In an effort to comprehend the aqueous chemistry of one of vanadium's oxidation states, namely, V(IV), implicated in its biological activity, reactions of VCl(3) and citric acid were pursued in water and led to V(IV)-citrate complexes, the nature and properties of which depend strongly on the solution pH. Analytical, FT-IR, UV/vis, EPR, and magnetic susceptibility data supported the formulation of X(4)[[VO(H(-1)Cit)](2)] x nH(2)O (H(-1)Cit = C(6)H(4)O(7)(4-); X = K(+), n = 6 (1); X = Na(+), n = 12 (2); X = NH(4)(+), n = 2 (3)) (pH approximately 8) and X(3)[[V(2)O(2)(H(-1)Cit)(Cit)]] x nH(2)O (X = K(+), n = 7 (4)) (pH approximately 5). Complex 2 crystallizes in space group P2(1)/c, a = 11.3335(9) A, b = 15.788(1) A, c = 8.6960(6) A, beta = 104.874(3) degrees, V = 1503.8(2), Z = 2. Complex 3 crystallizes in space group P one macro, a = 9.405(1) A, b = 10.007(1) A, c = 13.983(2) A, alpha = 76.358(4) degrees, beta = 84.056(4) degrees, gamma = 66.102(4) degrees, V = 1169.2(3), Z = 2. Complex 4 crystallizes in space group P2(1)nb, a = 9.679(4) A, b = 19.618(8) A, c = 28.30(1) A, V = 5374.0(4), Z = 8. The X-ray structures of 1-4 are V(2)O(2) dimers, with the citrate displaying varying coordination numbers and modes. 1 exhibits a small ferromagnetic interaction, whereas 4 exhibits an antiferromagnetic interaction between the V(IV) ions. 1 and 4 interconvert with pH, thus rendering the pH a determining factor promoting variable structural, electronic, and magnetic properties in V(IV)-citrate species. The observed aqueous behavior of 1-4 is consistent with past solution speciation studies, and contributes to the understanding of significant aspects of the biologically relevant vanadium(IV)-citrate chemistry.

No abstract

No abstract